Addus HomeCare vs AdaptHealth
ADUS and AHCO side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ADUS and AHCO compare
Addus HomeCare is the larger company, worth 2.2 times as much as AdaptHealth ($2.3B against $1.0B).
AdaptHealth grew revenue faster over the last twelve months (20.7% versus 11.5% for Addus HomeCare).
Addus HomeCare keeps more of each dollar of sales as profit, with a net margin of 7.4% compared with −11.4% at AdaptHealth.
Addus HomeCare scores higher on the StockData Score (20 against 7 for AdaptHealth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ADUS | AHCO |
|---|---|---|
| Size and price | ||
| Market cap | $2.3B | $1.0B |
| Share price | $123.00 | $7.66 |
| Change, 1 year | 8.2% | −17.8% |
| Change, 5 years | 22.5% | −66.7% |
| Beta (5Y) | 0.54 | 0.72 |
| Employees | 5,290 | 11K |
| StockData Score | ||
| Total score | 20 (better) | 7 |
| Valuation score | 5 (better) | 3 |
| Growth score | 4 (better) | 1 |
| Performance score | 5 (better) | 0 |
| Health score | 6 (better) | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 20.5× | – |
| P/S | 1.5× | 0.3× (better) |
| P/B | 1.9× | 0.9× (better) |
| EV/EBITDA | 12.9× (better) | 24.2× |
| P/FCF | 15.9× | 12.7× (better) |
| PEG | 0.91 | – |
| FCF yield | 6.3% | 7.8% (better) |
| Fair value | $144.79 | $19.52 |
| Margin of safety | 15.1% | 60.8% (better) |
| Growth | ||
| Revenue growth (TTM) | 11.5% | 20.7% (better) |
| Revenue growth, 5Y average | 13.2% | 25.2% (better) |
| Net income growth (TTM) | 29.7% (better) | −595% |
| EPS growth (TTM) | 28.5% (better) | −638% |
| EPS growth, 5Y average | 20.2% | – |
| Profitability | ||
| Gross margin | 32.3% (better) | 15.7% |
| Operating margin | 10.3% (better) | −8.9% |
| Net margin | 7.4% (better) | −11.4% |
| FCF margin | 9.6% (better) | 2.3% |
| Return on equity | 10.0% (better) | −28.6% |
| Return on invested capital | 10.5% (better) | −7.9% |
| Financial health | ||
| Debt / equity | 0.02 (better) | 1.54 |
| Net debt / EBITDA | −0.45 | 15.53 (better) |
| Interest coverage | 19.7× | – |
| Current ratio | 1.64 (better) | 1.13 |
| Altman Z-score | 7.11 (better) | 0.53 |
| Piotroski F-score | 6 (better) | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 104% | 104% |
| Held by insiders | 2.8% | 14.7% |
| Insider net buying, 12 months | −$20.7M | $49.1M (better) |
| Short interest, % of float | 5.5% | 9.4% |
Go deeper
- ADUS stock overview
- ADUS income statement
- ADUS valuation and score
- AHCO stock overview
- AHCO income statement
- AHCO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.